[Anticoagulant treatment in Horton's disease. A necessity during the initial phase of therapy with adrenal cortex hormones?].
J M
JM
Kerleau
H
H
Levesque
N
N
Cailleux
F
F
Héron
H
H
Courtois
J
J
Bourreille
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D017153:Antibodies, Anticardiolipin / Q000276:immunology*; D000925:Anticoagulants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D006801:Humans; D013927:Thrombosis / Q000209:etiology*
D000305:Adrenal Cortex Hormones; D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants
Traitement anticoagulant au cours de la maladie de Horton. Une nécessité à la phase initiale de la corticothérapie?